{"name":"Hualan Biological Engineering, Inc.","slug":"hualan-biological-engineering-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"A+C Meningococcal Polysaccharide Vaccine","genericName":"A+C Meningococcal Polysaccharide Vaccine","slug":"a-c-meningococcal-polysaccharide-vaccine","indication":"Prevention of meningococcal disease caused by Neisseria meningitidis serogroups A and C","status":"phase_3"},{"name":"Group ACYW135 Meningococcal Polysaccharide Vaccine","genericName":"Group ACYW135 Meningococcal Polysaccharide Vaccine","slug":"group-acyw135-meningococcal-polysaccharide-vaccine","indication":"Other","status":"phase_3"},{"name":"Influenza split vaccine","genericName":"Influenza split vaccine","slug":"influenza-split-vaccine","indication":"Seasonal influenza prevention in adults and children","status":"phase_3"}]}],"pipeline":[{"name":"A+C Meningococcal Polysaccharide Vaccine","genericName":"A+C Meningococcal Polysaccharide Vaccine","slug":"a-c-meningococcal-polysaccharide-vaccine","phase":"phase_3","mechanism":"This vaccine stimulates the immune system to produce antibodies against meningococcal serogroups A and C polysaccharide antigens, providing protection against meningococcal disease.","indications":["Prevention of meningococcal disease caused by Neisseria meningitidis serogroups A and C"],"catalyst":""},{"name":"Group ACYW135 Meningococcal Polysaccharide Vaccine","genericName":"Group ACYW135 Meningococcal Polysaccharide Vaccine","slug":"group-acyw135-meningococcal-polysaccharide-vaccine","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Influenza split vaccine","genericName":"Influenza split vaccine","slug":"influenza-split-vaccine","phase":"phase_3","mechanism":"A split influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against inactivated influenza virus antigens.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOZDRTUk9PbnhoWG5DQzhFR1VPN1c3NFJ6Q0VYcFlGV19PZktQWTQzdzB6czh4YUFucFJRQXJjU1VzSkZlZGJ3X3ZNcVZCcHlEWk9wYjd2dHRtc3p1VVBrMG8zSjdkUzFkcUQ4YmQzR3RON3k5bDBpd25qaGoyN2RHaU15ZjdGRDZ0NTd5dTVWZTJjbXFFM3VtdktHdGdQQ3ZVdkdjcWtzNGVlTTd0YnJ1WDlyQVZEWENlaUc2MnpMNDdqZ2x3NXpQa19zU1R3SWhTOF91bw?oc=5","date":"2026-03-24","type":"pipeline","source":"Markets Mojo","summary":"Hualan Biological Engineering Stock Hits Day Low Amid Price Pressure at CNY 14.14 - Markets Mojo","headline":"Hualan Biological Engineering Stock Hits Day Low Amid Price Pressure at CNY 14.14","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9wN0pDYlR4YWpsc04yamtFTnRTSjNOZV9mYlI4azE0dUFmTUJqQ2l3Mkg0eThNb3AzT0ctQUotRDZNV3NvbmVSd2gtQWFwbTJzQXEyWHlvUTNYc3QtUWVIbGR2akxrZ0cxUkVjVFFrS1liUDQ0VDdXZ0FRQ0hITk0?oc=5","date":"2026-03-24","type":"pipeline","source":"Markets Mojo","summary":"Hualan Biological Engineering Stock Hits Day Low Amid Price Pressure at CNY 14.14 - Markets Mojo","headline":"Hualan Biological Engineering Stock Hits Day Low Amid Price Pressure at CNY 14.14","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQRFZwRGRuRHctOXZEVVZLRmtMaVZDb1QzVFlteU9IenJVVkhVS2V3cFB0V2JNNFVHQ3JYcFRxOS1WeFBhZjlzdTJQN3lBMS1qQ3ZROTN3TlZSdF9TZ0lRUGZxSTVGMzlhMXk3WWxoWFhfU0xRZ25Ib2lyeThVYklPeHFjY01qVWttU3ZlN0dHZVpzLW1IcTJRY0pTQUNubVQ2WWdSS3dpdWpISjBkel9FVw?oc=5","date":"2025-03-31","type":"pipeline","source":"Bloomberg.com","summary":"Chinese Biotech Eyes US Nod for Cancer Therapy Eluding Merck - Bloomberg.com","headline":"Chinese Biotech Eyes US Nod for Cancer Therapy Eluding Merck","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE93S2djVVNIY3pwM1Rfc2dic1BGazNfd2NHdFZZMUtlOGpDSlRZTDRVSk1JcU1NeFpYdXJFMmNMZlFfdTlVWTNVcXc0c3ZqU05LV2dtTzRvRHhRdWhMSEt3ZjlBalN4LW10OWt2UVRoWUI?oc=5","date":"2019-12-12","type":"regulatory","source":"Straits Research","summary":"Colloids (Blood Plasma) Market Size, Demand 2033 - Straits Research","headline":"Colloids (Blood Plasma) Market Size, Demand 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQUG5KYjNXamZDTFlPb3Y1UUttc1lFRExPbHJqR1dMeFNfT1h3T1FpVThXUm9mVS00aERmZHNGU0xRNTV1OUJadmN5b3hlOXY0SURYYkdrMm5fY0h3T0VWZHVUa1g2MUtCSWJLSEJhN29RRWROOS1wQWdNNXdnV1Q5RDZnQTBBRkZKb3hXUkJPMmVMR0JvVmdUUlJIRHpYZ1FvMldZa1JZVkw5YTJDa3UybGhOQQ?oc=5","date":"2019-07-30","type":"pipeline","source":"BioSpectrum India","summary":"Flu vaccine market to reach approx $8B by 2029 - BioSpectrum India","headline":"Flu vaccine market to reach approx $8B by 2029","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNMmh5S0IzenNwRUZzT2lwUnJYNVhqckRpR1ppWmRuNVZGbWMxWDRCUnR3Qk9YTTBtbnkwWWpsVkZiRlNudW4tUVhmRmkwUVVqeFY1X0hHYms5dldSeXlWaEx3VXpzMk5EdEdtbzY1aUQ0ak9HeERoQm9jeGF2YkRTbEVVcTZzXzJFaU5yRHpRMnJkVlpV?oc=5","date":"2019-07-02","type":"pipeline","source":"openPR.com","summary":"What's driving the Fibrin Glue Market Size? | Key Players - openPR.com","headline":"What's driving the Fibrin Glue Market Size? | Key Players","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPaXFsend3Z0dKbEdxYWowa2MwLW9TZWUxWDJFTF9LUm9JOGFwLWV4RXBnTVdiMVZBNVp3bVlWQkFWSjhYclN1VmF6T0lHVlByNFk0U2RjdDVNNERtTTV4ZEZTVkYxV3lFVGpEdzNYWFh0TmRQVnlNUm12cU0ydDY0UUJ5TkJEUUVVQ3dZMnFNZXhXdlpvQjd4ZFlyM0dadndqb01lRGpPZTB1Ymxkb0k1bENKQlJWMjlYSGd5cw?oc=5","date":"2018-08-21","type":"pipeline","source":"Fierce Pharma","summary":"Investors led by former CEO offer $3.9B for plasma producer China Biologic - Fierce Pharma","headline":"Investors led by former CEO offer $3.9B for plasma producer China Biologic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFA2bkd6VE5oR3FCbTdfYUdGYlIzTWFwUGZCVjlHbjFQVjRZM3NJOVZoaVBwSTlIM3ZWOU9NZm0wOFZteHdueVZZTVNJeGdsdGhZMkxsTkl3VndONnk5M0gybWNYb1NjaVE4LWltM3FZVXplcUM4?oc=5","date":"2015-05-15","type":"pipeline","source":"Allied Market Research","summary":"Meningococcal Vaccines Market Size, Share & Growth, 2032 - Allied Market Research","headline":"Meningococcal Vaccines Market Size, Share & Growth, 2032","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQWFA3ZlVHZGpOVVJONndfQzFhT2pYS3VuZmlabDBZSmQyN3d4aU1zSXZUMDdaMG82Qm1PNk5BaTNEVWJoZFpkSkU3N1VMREhwWklVc2VnbHNPNTdBZXN4V3RKV0xQcGZjNGFFM1BRRXV3QVFRQ043OTVRVnQzN0pMaQ?oc=5","date":"2015-05-15","type":"pipeline","source":"Allied Market Research","summary":"Intravenous Immunoglobulin Market Share Report, 2033 - Allied Market Research","headline":"Intravenous Immunoglobulin Market Share Report, 2033","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":3},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}